Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Sep. 24, 2016	Sep. 26, 2015
Cash flows from operating activities:
Net income	$ 93,929	$ 68,234
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	32,961	28,021
Stock compensation expense	19,234	16,954
Deferred income taxes	13,908	10,047
Loss on retirement or write-off of long-lived assets	251	162
Actuarial (gain) loss amortization on defined benefit pension plan	(36)	19
Excess tax benefit from employee stock awards	(4,631)	(2,850)
Other non-cash charges	(2,867)	8,993
Net change in operating assets and liabilities:
Accounts receivable, net	(181,027)	(56,735)
Inventories	(19,239)	(59,671)
Other current assets	4,620	774
Accounts payable and other accrued liabilities	64,475	(856)
Deferred income		(523)
Income taxes payable	10,638	(12,598)
Net cash provided by (used in) operating activities	32,216	(29)
Cash flows from investing activities:
Maturities and sales of available-for-sale marketable securities	91,531	98,019
Purchases of available-for-sale marketable securities	(128,415)	(22,605)
Purchases of property, equipment and software	(18,119)	(22,023)
Investments in technology	(5,743)	(2,851)
Acquisition of businesses, net of cash obtained		(37,216)
Increase in deposits and other assets		(163)
Net cash (used in) provided by investing activities	(60,746)	13,161
Cash flows from financing activities:
Principal payments on long-term revolver	(20,439)	(20,000)
Debt issuance costs	(2,152)
Payments on capital lease agreements	(699)
Issuance of common stock, net of shares withheld for taxes	9,131	3,945
Repurchase of stock to satisfy employee tax withholding obligations	(2,031)	(791)
Repurchase and retirement of common stock	(15,440)	(19,204)
Excess tax benefit from employee stock awards	4,631	2,850
Net cash used in financing activities	(26,999)	(33,200)
Net decrease in cash and cash equivalents	(55,529)	(20,068)
Cash and cash equivalents at beginning of period	168,793	168,793
Cash and cash equivalents at end of period	$ 113,264	$ 56,333